Aceclidine
CAS No. 827-61-2
Aceclidine( Glaucostat | 3-Acetoxyquinuclidine | 3-quinuclidinyl acetate | 1-azabicyclo[2.2.2]octan-3-yl acetate | Quinuclidin-3-yl acetate )
Catalog No. M27183 CAS No. 827-61-2
Aceclidine is an agent that is used for treating glaucoma by reducing intraocular pressure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 48 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAceclidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAceclidine is an agent that is used for treating glaucoma by reducing intraocular pressure.
-
DescriptionAceclidine is an agent that is used for treating glaucoma by reducing intraocular pressure.
-
In Vitro——
-
In Vivo——
-
SynonymsGlaucostat | 3-Acetoxyquinuclidine | 3-quinuclidinyl acetate | 1-azabicyclo[2.2.2]octan-3-yl acetate | Quinuclidin-3-yl acetate
-
PathwayOthers
-
TargetOther Targets
-
RecptorDengue Fever virus| Ebola virus| HCV| HIV-1| Rift Valley virus
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number827-61-2
-
Formula Weight169.224
-
Molecular FormulaC9H15NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (590.95 mM)
-
SMILESCC(=O)OC1CN2CCC1CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Aman MJ, et al. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Res. 2009 Sep;83(3):245-51.
molnova catalog
related products
-
JAMM protein inhibit...
JAMM protein inhibitor 2?is an inhibitor of JAMM protease and can be used for anticancer studies. The IC50s are 10 μM, 46 μM, and 89 μM for thrombin, Rpn11, and MMP2, respectively.
-
Osteogenic Growth Pe...
Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations. Osteogenic growth peptide OGP is a key factor in the mechanism of the systemic osteogenic response to local bone marrow injury.
-
Opigolix
Opigolix, a Gonadotropin-releasing hormone receptor antagonist, treats hormone-dependent conditions by inhibiting the actions of gonadotropin-releasing hormone (GnRH).
Cart
sales@molnova.com